Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

August 01, 2008 (Vol. 28, No. 14)

Is the U.K. Biotech Industry on the Skids?

Lack of Investment Is the Culprit, According to Those in the Know

  • If you listened to certain speakers at the recent ERBI “Cambridge Biopartnering Exchange,” it would seem as if the glory days of U.K. biotech are over. Only Abcam, a Cambridge-based research antibody supply company, was held up as a example of how U.K. biotechs need to be to survive. ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.